Research Overview
Semaglutide is a GLP-1 receptor agonist analog with a C18 fatty acid modification enabling albumin binding and extended half-life in pharmacokinetic research models. In vitro research applications include GLP-1R binding studies, cAMP signaling pathway analysis, beta-cell function models, and metabolic pathway research. This is a highly regulated research compound.
Compound Specifications
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
|---|---|
| Molecular Weight | 4,113.6 Da |
| CAS Number | 910463-68-2 |
| Sequence | His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-ε-(N-(2-(2-(2-((2-(2-(3-carboxypropanoyloxy)ethoxy)ethyl)amino)-2-oxoethoxy)ethoxy)acetyl)octadecanedioyl-γGlu))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-NH₂ |
| Purity | >98% (HPLC verified) |
| Storage | Store at -20°C. Stable 24 months lyophilized. Do not freeze-thaw repeatedly. |
| Form | Lyophilized powder |
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
Certificate of Analysis
Each batch is third-party tested. COA available upon request — contact us with your order number.


Reviews
There are no reviews yet.